TLX fundamentals
An in-depth look to TELIX PHARMACEUTICALS LIMITED operating, investing, and financing activities
TLX free cash flow for H1 24 is 30.21 M AUD. For 2023, TLX free cash flow was 14.21 M AUD and operating cash flow was 23.88 M AUD.
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: AUD
Q1 '24
TTM